Diagnostic Criteria For Neurofibromatosis Type 1 (2021)
Children's Tumor Foundation | 2021
Visit WebsiteChildren's Tumor Foundation | 2021
Visit WebsiteChildren's Tumor Foundation
Visit WebsiteChildren's Tumor Foundation | 2024
Visit Website
Recursion Pharmaceuticals Inc.
This is a parallel-group, two-staged, Phase 2/3, randomized, multi-center study to investigate the efficacy and safety of REC-2282 in patients…
View Article
2024 NF Midwest iNFo Fair
| 2024
By Miranda McManus, MS
Children's Tumor Foundation | 2023
Visit WebsiteChildren's Tumor Foundation | 2024
Visit Website
MedlinePlus.gov
| 2021
By National Institutes of Health
Global Genes Alliance | 2021
Download ArticleStanford Ophthalmology, Children's Hospital of Philadelphia and Gilbert Family Foundation | 2024
This study is seeking to learn how different eye tests and devices can help understand vision in patients with NF1,…
View Article
© 2025 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.